Emma Thornhill - Paxman AB Head Fin

PAX Stock  SEK 70.00  2.20  3.24%   

Insider

Emma Thornhill is Head Fin of Paxman AB
Age 38
Phone46 7 09 43 96 71
Webhttps://paxmanscalpcooling.com

Paxman AB Management Efficiency

The company has return on total asset (ROA) of (0.0412) % which means that it has lost $0.0412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0254) %, meaning that it generated substantial loss on money invested by shareholders. Paxman AB's management efficiency ratios could be used to measure how well Paxman AB manages its routine affairs as well as how well it operates its assets and liabilities.
Paxman AB has accumulated 5.83 M in total debt with debt to equity ratio (D/E) of 76.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Paxman AB has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Paxman AB until it has trouble settling it off, either with new capital or with free cash flow. So, Paxman AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paxman AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paxman to invest in growth at high rates of return. When we think about Paxman AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Katrin GisselfaltXvivo Perfusion AB
54
Slavoljub GrujicicSenzime AB
53
Johan FolkungerSpectraCure AB
55
Kristina HolstSpectraCure AB
N/A
Henrik LjungSpectraCure AB
65
Mirjam JohanssonSpectraCure AB
N/A
Jaya TiwariXvivo Perfusion AB
N/A
Johan HolmstromXvivo Perfusion AB
53
Andreas MDXvivo Perfusion AB
46
Kristoffer NordstromXvivo Perfusion AB
38
Johannes SwartlingSpectraCure AB
51
Johanna TulkkiSenzime AB
53
Anders SelinSenzime AB
61
Lena BScXvivo Perfusion AB
58
Charlotte WalldalXvivo Perfusion AB
56
Paxman AB , together with its subsidiaries, develops and sells PAXMAN scalp cooling system for minimizing hair loss in connection with chemotherapy treatment in Europe, North-and South America, Asia, and Australia. The company was founded in 1996 and is headquartered in Karlshamn, Sweden. Paxman AB is traded on Stockholm Stock Exchange in Sweden. Paxman AB (PAX) is traded on Stockholm Exchange in Sweden and employs 76 people.

Management Performance

Paxman AB Leadership Team

Elected by the shareholders, the Paxman AB's board of directors comprises two types of representatives: Paxman AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paxman. The board's role is to monitor Paxman AB's management team and ensure that shareholders' interests are well served. Paxman AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paxman AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Patrick Burke, Head Operations
Emma Thornhill, Head Fin
Emelie Gustafsson, Chief Officer
Claire Paxman, Director Initiatives
Anna Parker, Head Sales
Liza Hirst, EA HR
Stuart Rowling, Head Sales
Richard Paxman, CEO Director
Susy Brown, Head Marketing
Alexandra Sheldrake, Head Affairs

Paxman Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Paxman AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Paxman Stock Analysis

When running Paxman AB's price analysis, check to measure Paxman AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paxman AB is operating at the current time. Most of Paxman AB's value examination focuses on studying past and present price action to predict the probability of Paxman AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paxman AB's price. Additionally, you may evaluate how the addition of Paxman AB to your portfolios can decrease your overall portfolio volatility.